Operose Advisors’s Mesa Laboratories MLAB Stock Holding History

Operose Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-65	Closed	-$6.83K	–	682
2023 Q3	$6.83K	Buy	+65	New	+$8.33K	﹤0.01%	628

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Operose Advisors's MLAB Position: Q4 2023 in Review

Operose Advisors sold out of Mesa Laboratories (MLAB) in Q4 2023, closing a stake of 65 shares — an estimated $6.83K sold.

Operose Advisors first reported a position in MLAB in Q3 2023 and held it in 1 quarter. The position peaked at $6.83K in Q3 2023. 158 funds tracked by Wall St. Rank hold MLAB as of Q4 2023.

Operose Advisors reported no remaining Mesa Laboratories position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 65 Mesa Laboratories shares in Q4 2023, an estimated $6.83K.
Operose Advisors first reported a position in Mesa Laboratories in Q3 2023 and held it in 1 quarter.
Operose Advisors's Mesa Laboratories position peaked at $6.83K in Q3 2023.
158 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.